Literature DB >> 2193785

Malignant lymphoma in ulcerative colitis. Report of a case.

A M Abulafi1, R V Fiddian.   

Abstract

The authors present the case of a 40-year-old woman with primary malignant lymphoma complicating chronic ulcerative colitis. Twenty-one cases reported in the literature are reviewed and the various available data analyzed. Variations in the distribution of lymphoma in both the normal and colitic bowel supports a relationship between both conditions. Any lymphocytic infiltrate seen in biopsies obtained from ulcerative colitis should be assessed to exclude associated lymphoma. The prognosis is poor.

Entities:  

Mesh:

Year:  1990        PMID: 2193785     DOI: 10.1007/bf02052219

Source DB:  PubMed          Journal:  Dis Colon Rectum        ISSN: 0012-3706            Impact factor:   4.585


  4 in total

Review 1.  Mechanisms of intestinal inflammation and development of associated cancers: lessons learned from mouse models.

Authors:  Aya M Westbrook; Akos Szakmary; Robert H Schiestl
Journal:  Mutat Res       Date:  2010-03-16       Impact factor: 2.433

2.  Mantle zone lymphoma of the colon simulating diffuse inflammatory bowel disease. Role of immunohistochemistry in establishing the diagnosis.

Authors:  J E McCullough; C H Kim; P M Banks
Journal:  Dig Dis Sci       Date:  1992-06       Impact factor: 3.199

3.  Primary CD56+ NK/T-cell lymphoma of the rectum accompanied with refractory ulcerative colitis.

Authors:  Kazuki Kakimoto; Takuya Inoue; Takashi Nishikawa; Kumi Ishida; Ken Kawakami; Takanori Kuramoto; Yosuke Abe; Eijiro Morita; Naoko Murano; Ken Toshina; Mitsuyuki Murano; Eiji Umegaki; Yutaro Egashira; Junji Okuda; Nobuhiko Tanigawa; Ichiro Hirata; Ken-Ichi Katsu; Kazuhide Higuchi
Journal:  J Gastroenterol       Date:  2008-07-23       Impact factor: 7.527

Review 4.  Colitis ulcerosa complicated by malignant lymphoma: case report and analysis of published works.

Authors:  R Lenzen; F Borchard; H Lübke; G Strohmeyer
Journal:  Gut       Date:  1995-02       Impact factor: 23.059

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.